Showing results (61-70 of 217) with videos related to
Sort By:
Pageof 22
Future Oncology (London, England)|August 16, 2023
Phase II biomarker identification study of anti-VEGF agents with FOLFIRI for pretreated metastatic colorectal cancerTadayoshi Hashimoto, Satoshi Otsu, Shuichi Hironaka, et al.Anticancer Research|March 10, 2015
Safety and efficacy of adjuvant therapy with oxaliplatin, leucovorin and 5-fluorouracil after mesorectal excision with lateral pelvic lymph node dissection for stage iii lower rectal cancerSatoru Iwasa, Hiroaki Souda, Kentaro Yamazaki, et al.Japanese Journal of Clinical Oncology|September 23, 2016
A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study)Masayuki Ohue, Satoru Iwasa, Yukihide Kanemitsu, et al.Journal of Cancer Research and Clinical Oncology|December 29, 2009
Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancerKenji Hashimoto, Atsuo Takashima, Kengo Nagashima, et al.Hepato-Gastroenterology|December 13, 2005
Small cell carcinoma of the esophagus. Analysis of 14 cases and literature reviewAyumu Hosokawa, Yasuhiro Shimada, Yasuhiro Matsumura, et al.Cancer Chemotherapy and Pharmacology|January 27, 2009
A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumorsKuniaki Shirao, Takayuki Yoshino, Narikazu Boku, et al.Cancer Chemotherapy and Pharmacology|February 23, 2017
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysisToshihiko Doi, Tetsuya Hamaguchi, Kohei Shitara, et al.Cancer Letters|May 7, 2005
Establishment of an apoptosis-sensitive rat mammary carcinoma cell line with a mutation in the DNA-binding region of p53Tetsuya Hamaguchi, Yoichiro Matsuoka, John Bechberger, et al.American Journal of Clinical Oncology|April 11, 2002
Prognostic factors for patients with metastatic colorectal cancer receiving protracted venous infusion of 5-FUYoshihisa Namiki, Kei Muro, Kuniaki Shirao, et al.International Journal of Clinical Oncology|May 14, 2015
Clinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance studyMasahiro Osawa, Shoji Kudoh, Fumikazu Sakai, et al.Pageof 22